2018 annual financial data
Emergent BioSolutions 2018 Operating margin
Direct answer
Operating margin was 11.48%.
Operating income was 89,800,000 USD and net income was 62,700,000 USD.
Operating cash flow was 41,800,000 USD.
Get free Emergent BioSolutions email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 782,400,000 USD
- Operating income
- 89,800,000 USD
- Net income
- 62,700,000 USD
- Operating cash flow
- 41,800,000 USD